Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    22873532 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting Induction Chemotherapy (R-CHOP Vs. R-FC) Followed by Interferon Maintenance Versus Rituximab Maintenance in MCL
Condition: Lymphoma, Mantle-Cell
Interventions: Drug: Rituximab;   Drug: Cyclophosphamide;   Drug: Doxorubicin;   Drug: Vincristine;   Drug: Prednisone;   Drug: Fludarabine;   Drug: Interferon-alpha;   Drug: pegylated formula Interferon-alpha 2b;   Procedure: chemotherapy: R-CHOP;   Procedure: chemotherapy: R-FC;   Procedure: Interferon maintenance;   Procedure: Rituximab maintenance

Indicates status has not been verified in more than two years